RBFC
OMCL icon

Roman Butler Fullerton & Co’s Omnicell OMCL Stock Holding History

Roman Butler Fullerton & Co’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,420
Closed -$466K – 181
2019
Q2 		$466K Buy
+5,420
New +$440K 0.31% 106

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Conestoga Capital Advisors
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Eagle Asset Management
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Roman Butler Fullerton & Co's OMCL Position: Q3 2019 in Review

Roman Butler Fullerton & Co sold out of Omnicell (OMCL) in Q3 2019, closing a stake of 5,420 shares — an estimated $466K sold.

Roman Butler Fullerton & Co first reported a position in OMCL in Q2 2019 and held it in 1 quarter. The position peaked at $466K in Q2 2019. 279 funds tracked by Wall St. Rank hold OMCL as of Q3 2019.

  • Roman Butler Fullerton & Co reported no remaining Omnicell position as of Q3 2019 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 5,420 Omnicell shares in Q3 2019, an estimated $466K.
  • Roman Butler Fullerton & Co first reported a position in Omnicell in Q2 2019 and held it in 1 quarter.
  • Roman Butler Fullerton & Co's Omnicell position peaked at $466K in Q2 2019.
  • 279 funds tracked by Wall St. Rank held Omnicell as of Q3 2019.

Based on Roman Butler Fullerton & Co's 13F filing for Q3 2019, filed 15 Oct 2019.